Privia Health Group, Inc. PRVA
Nasdaq · stock · Services-Health Services · website · IPO 2021-04-29
Privia Health Group, Inc. financials (annual)
Bars are annual figures from 2020 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $2.1B | $1.7B | $1.7B | $1.4B | $966.2M | $817.1M |
| Operating income | $34.2M | $17.0M | $20.6M | -$19.1M | -$217.4M | $25.4M |
| Interest expense | — | — | — | $500,000 | $1.1M | $1.9M |
| Income tax | $14.2M | $10.8M | $8.0M | -$6.5M | -$27.9M | -$7.4M |
| Net income | $22.9M | $14.4M | $23.1M | -$8.6M | -$188.2M | $31.2M |
| EPS (diluted) | $0.18 | $0.11 | $0.19 | $-0.08 | $-1.83 | $0.33 |
| Operating cash flow | $163.4M | $109.3M | $80.8M | $47.2M | $55.1M | $38.9M |
| Free cash flow | — | — | $80.7M | $47.1M | $54.5M | $38.5M |
| Cash & equivalents | $479.7M | $491.1M | $389.5M | $348.0M | $320.6M | $84.6M |
| Total assets | $1.4B | $1.1B | $999.9M | $792.8M | $686.4M | $329.0M |
| Total liabilities | $578.4M | $452.3M | $392.5M | $273.8M | $236.2M | $185.3M |
| Shareholders' equity | $790.9M | $683.4M | $607.4M | $519.0M | $450.2M | $146.7M |
Growth · year-over-year · Revenue CAGR 21%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue growth | +22.3% | +4.7% | +22.2% | +40.4% | +18.3% | — |
| Net income growth | +59.3% | -37.7% | — | — | -702.5% | — |
| EPS growth | +63.6% | -42.1% | — | — | -654.5% | — |
| Free cash flow growth | — | — | +71.3% | -13.6% | +41.5% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.